Pharmacokinetics and renal function in preterm infants

被引:61
|
作者
vandenAnker, JN [1 ]
机构
[1] ERASMUS UNIV ROTTERDAM, DEPT PEDIAT, ROTTERDAM, NETHERLANDS
关键词
clinical pharmacokinetics; development pharmacology; glomerular filtration rate; neonatal pharmacology; preterm infants; renal function;
D O I
10.1111/j.1651-2227.1996.tb13942.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
There is an increase in the survival rate of preterm infants due to rapid advances in medical knowledge and technology. However, the research and attention paid to the proper use of pharmacotherapy in these infants is still a relatively underdeveloped field. Effective and safe drug therapy requires a thorough understanding of human developmental biology and of the dynamic ontogeny of drug absorption, drug disposition? drug metabolism, and drug excretion. It is apparent that maturation of organ system function and changes in body composition during gestation and during the neonatal period exert a significant effect on the disposition of drugs. This review focuses on the effects of maturational and drug-induced changes in renal function on clinical pharmacokinetics in the preterm infant.
引用
收藏
页码:1393 / 1399
页数:7
相关论文
共 50 条
  • [1] Ceftazidime pharmacokinetics in preterm infants: Effects of renal function and gestational age
    vandenAnker, JN
    Schoemaker, RC
    Hop, WCJ
    vanderHeijden, BJ
    Weber, A
    Sauer, PJJ
    Neijens, HJ
    deGroot, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (06) : 650 - 659
  • [2] Renal function in preterm infants
    vandenAnker, JN
    EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (07) : 583 - 584
  • [3] Renal function in small for gestational age preterm infants
    Hany Aly
    Zahraa Ez El Din
    Reem M. Soliman
    Indrani Bhattacharjee
    May A. K. Abdellatif
    Abdelkarim Kamel
    Hemmat Salah
    Journal of Perinatology, 2019, 39 : 1263 - 1267
  • [4] Renal function in small for gestational age preterm infants
    Aly, Hany
    El Din, Zahraa Ez
    Soliman, Reem M.
    Bhattacharjee, Indrani
    Abdellatif, May A. K.
    Kamel, Abdelkarim
    Salah, Hemmat
    JOURNAL OF PERINATOLOGY, 2019, 39 (09) : 1263 - 1267
  • [5] Pharmacokinetics of Melatonin in Preterm Infants
    N Merchant
    D Azzopardi
    D Edwards
    Pediatric Research, 2011, 70 : 681 - 681
  • [6] Pharmacokinetics of oxatomide in preterm infants
    Dani, C
    Martelli, E
    Bertini, G
    Filippi, L
    Pezzati, M
    Mazzetti, L
    Ciuffi, M
    Zilletti, L
    Rubaltelli, FF
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2002, 28 (05) : 207 - 210
  • [7] CEFOPERAZONE PHARMACOKINETICS IN PRETERM INFANTS
    BOSSO, JA
    CHAN, GM
    MATSEN, JM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (03) : 413 - 415
  • [8] ERYTHROPOIETIN PHARMACOKINETICS IN PRETERM INFANTS
    KRISHNAN, R
    SHANKARAN, S
    KRISHNAN, M
    KAUFFMAN, R
    KUMAR, P
    LUCENA, J
    GRIETSELL, L
    PEDIATRIC RESEARCH, 1995, 37 (04) : A78 - A78
  • [9] Pharmacokinetics of melatonin in preterm infants
    Merchant, Nazakat M.
    Azzopardi, Denis V.
    Hawwa, Ahmed F.
    McElnay, James C.
    Middleton, Benita
    Arendt, J.
    Arichi, Tomoki
    Gressens, Pierre
    Edwards, A. David
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) : 725 - 733
  • [10] ALFENTANIL PHARMACOKINETICS IN PRETERM INFANTS
    MARLOW, N
    WEINDLING, AM
    VANPEER, A
    HEYKANTS, J
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1990, 65 (04): : 349 - 351